Frontiers in Cardiovascular Medicine

JANUARY 11, 2024

Objective Early risk assessment of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) is crucial to ensure timely treatment. We hypothesize that applying artificial intelligence (AI) to chest x-rays (CXRs) could identify the future risk of PAH in patients with ventricular septal defect (VSD).

VSD 59

VSD Pulmonary Congenital Heart Disease Congenital 59

All About Cardiovascular System and Disorders

FEBRUARY 14, 2024

Crochetage sign on ECG in ASD ECG in ASD with severe pulmonary hypertension: Tall R’ in V1, ST depression in inferior leads and V2-V5, and T inversion in inferior leads and V1-V6 are seen. The sign has been described in VSD with biventricular hypertrophy in children.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease VSD 52

Dr. S. Venkatesan MD

APRIL 18, 2024

Lowering the raised LA mean pressure is a major therapeutic goal in any severely symptomatic left heart disease, whether it is valvular or myocardial disease. Curious minds might ask, can’t we decompress LV it self by creating a small VSD. Probably in the thin membranous area.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Pulmonary Congenital Heart Disease VSD 40

All About Cardiovascular System and Disorders

MARCH 20, 2024

Right atrial hypertrophy as in tricuspid stenosis, pulmonary stenosis and pulmonary hypertension. But in a VSD with pulmonary hypertension A wave is not prominent. So a prominent A wave in a complex congenital heart disease situation would indicate that interventricular septum is intact.

Tricuspid 52

Tricuspid Pericarditis VSD Heart Failure 52